Page last updated: 2024-10-28

hydroxychloroquine and B16 Melanoma

hydroxychloroquine has been researched along with B16 Melanoma in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y2
Zhou, Z1
Chen, W1
Qin, M2
Zhang, Z2
Gong, T1
Sun, X1
Shi, K1
Zhang, L1
Hu, G1
Wan, J1
Tang, J1
Yin, S1
Duan, J1
Wang, N1
Xie, D1
Gao, X1
Gao, H1
He, Q1

Other Studies

2 other studies available for hydroxychloroquine and B16 Melanoma

ArticleYear
Potentiating bacterial cancer therapy using hydroxychloroquine liposomes.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 06-28, Volume: 280

    Topics: Animals; Antineoplastic Agents; Autophagy; Bacterial Vaccines; Cell Line, Tumor; Cell Survival; Cyto

2018
Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
    Autophagy, 2016, 06-02, Volume: 12, Issue:6

    Topics: Animals; Antineoplastic Agents; Autophagy; Biophysical Phenomena; Doxorubicin; Drug Delivery Systems

2016